Related Experiment Video
Updated: Jul 13, 2026
08:31
Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
Evaluation of two cationic delivery systems for siRNA
Preeti Yadava1, Daniel Roura, Jeffrey A Hughes
1Department of Pharmaceutics, University of Florida, Gainesville, FL 32610, USA.
Oligonucleotides
|July 20, 2007
Summary
Cationic vectors like liposomes and polymers effectively deliver small interfering RNA (siRNA) for RNA interference (RNAi). Liposomes showed greater siRNA activity, suggesting vector decomplexation is key for therapeutic development.
Area of Science:
- Biochemistry
- Molecular Biology
- Nanotechnology
Background:
- Small interfering RNA (siRNA) is a potent tool for RNA interference (RNAi), enabling targeted mRNA degradation.
- Effective delivery of siRNA to the cell cytoplasm is crucial for its therapeutic potential.
- Cationic macromolecules, including lipids and polymers, are investigated for siRNA delivery.
Purpose of the Study:
- To compare the efficacy of two model cationic vectors: liposomes (lipoplexes) and polyethylenimine (PEI, polyplexes) for siRNA delivery.
- To evaluate the impact of vector choice on siRNA cellular uptake, decomplexation, and biological activity.
Main Methods:
- siRNA complexation with lipoplexes and polyplexes.
- Assessment of cellular uptake using flow cytometry.
- Evaluation of siRNA biological activity using siTOX siRNA and measuring cell death.
Main Results:
- Lipoplexes and polyplexes exhibited similar cellular uptake rates.
- Lipoplexes demonstrated easier siRNA decomplexation compared to polyplexes.
- Lipoplex-mediated siRNA delivery resulted in dose-dependent cell death, with 76.4% observed at 80 nmol siTOX.
Conclusions:
- The choice of cationic vector significantly influences the biological activity of siRNA.
- Efficient siRNA decomplexation from the delivery vector is a critical factor for enhancing RNAi efficacy.
- These findings guide the development of improved siRNA delivery systems for clinical applications.
Related Concept Videos
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...